Bachert, C., Fokkens, W., Hellings, P., Scadding, G., Munzel, U., & Mullol, J. (2015). A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. Clin Transl Allergy.

Bachert, Claus, Wytske Fokkens, Peter Hellings, Glenis Scadding, Ullrich Munzel, ja Joaquim Mullol. "A New Intranasal Therapy (MP29-02*) Is More Effective Than Current Firstline Therapy Regardless of Season, Symptom or Severity." Clin Transl Allergy 2015.

Bachert, Claus, et al. "A New Intranasal Therapy (MP29-02*) Is More Effective Than Current Firstline Therapy Regardless of Season, Symptom or Severity." Clin Transl Allergy 2015.